Opportunity
Simpler Grants.gov #PAR-24-027
NIH PATH Study Biospecimen and Data Access for Research
Buyer
National Institutes of Health
Posted
August 24, 2023
Respond By
October 30, 2026
Identifier
PAR-24-027
NAICS
541714, 541715
This opportunity from the National Institutes of Health (NIH) offers research organizations access to valuable biospecimens and data from the PATH Study: - Government Buyer: - National Institutes of Health (NIH), Drug Abuse and Addiction Research Programs - Products/Services Requested: - Access to government-held biospecimens: urine, plasma, serum, and genomic DNA - Associated research data on tobacco use behaviors, attitudes, biomarkers, and health outcomes in the U.S. - OEMs and Vendors: - No commercial OEMs or vendors are involved; all materials are government-held - Unique/Notable Requirements: - Only U.S.-based organizations are eligible (no foreign entities or non-U.S. components) - Eligible applicants include educational institutions, businesses, government agencies, and nonprofits - Access is for research purposes only, not for commercial resale or product development - Place of Performance: - National Institutes of Health (NIH)
Description
This opportunity allows investigators to apply for access to biospecimens (urine, plasma, serum, and genomic DNA) and related research data from the Population Assessment of Tobacco and Health (PATH) Study. The PATH Study provides data on behaviors, attitudes, biomarkers, and health outcomes associated with tobacco use in the U.S. Eligible applicants include a wide range of organizations such as educational institutions, businesses, government entities, and nonprofits. The opportunity is administered by the National Institutes of Health under the Drug Abuse and Addiction Research Programs. More information and application instructions are available on the Grants.gov portal and the NIH website.